About Us Media Room

Media Room

Juvenescence

M2Bio Sciences Interview: Dr. Greg Bailey Goes Deep on Juvenescence, Longevity Biotech, and His Personal Story

Dr. Greg Bailey, MD, CEO of Juvenescence, conducts an interview with M2Bio Sciences. In the interview, Greg shares his insights on Juvenescence, longevity biotech, entrepreneurship, and his personal story.

September 14, 2020

Read More
Relation Therapeutics

Longevity Technology: 'Relation-Mila collaboration wins $1.3m Gates Foundation Award to fight COVID-19'

Relation Therapeutics and Mila, the Montreal-based AI research institute are collaborating on a new project targeting the development of COVID-19 therapeutics funded by the Bill & Melinda Gates Foundation.

September 1, 2020

Read More
Juvenescence

Allure: ‘Our Average Life Expectancy Could Increase to 115 Years Very Soon’

Dr. Greg Bailey, CEO of Juvenescence shares his insights on the future of aging with Allure. He discusses increasing lifespan in humans, a burst of investment in the longevity space and Juvenescence’s plans to bring that future to life.

August 17, 2020

Read More
LyGenesis

Longevity Technology: 'Hufford interview: “It’s worth pointing out just how remarkable this is.”'

LyGenesis CEO Michael Hufford talks to Longevity Technology about Longevity research programs and investment.

July 22, 2020

Read More
Juvenescence

The Simple Biotech Podcast: ‘Investing in the Longevity Industry: The Greatest Investment Opportunity in Human History’

Dr. Greg Bailey, MD, CEO of Juvenescence discusses innovations in the longevity space in this interview with host James Ruhle of ‘The Simple BioTech Podcast’.

July 6, 2020

Read More
Juvenescence

Longevity Technology: ‘Juvenescence CEO on near-term Longevity breakthroughs’

Dr. Greg Bailey, MD gives an interview to Longevity Technology on near-term longevity breakthroughs, including the latest developments at Juvenescence and dealing with the impact of COVID-19.

April 19, 2020

Read More
Juvenescence

Longevity Technology: ‘Greg Bailey on Democratizing Healthcare, Paradigm Shifts & Disruptive Technologies’

Dr. Greg Bailey, CEO of Juvenescence gives an interview to Longevity Technology to discuss his thoughts on the longevity field and future plans for Juvenescence.

September 25, 2019

Read More
LyGenesis

Longevity Technology: ‘Exclusive profile: LyGenesis and growing ectopic organs’

Michael Hufford, CEO of LyGenesis, speaks with Longevity Technology about revolutionary regenerative technology and plans for clinical development.

September 24, 2019

Read More
Insilico Medicine

Nature Biotech: ‘Deep learning enables rapid identification of potent DDR1 kinase inhibitors’

Insilico Medicine, a Juvenescence partner, recently highlighted their ability to use deep learning for de novo small-molecule design in Nature Biotech.

September 20, 2019

Read More
Juvenescence

Forbes: ‘Extraordinary breakthroughs in Anti-Aging Research ‘Will Happen Faster Than People Think’

Scientific breakthroughs in anti-aging research have been occurring at an exponential pace, as highlighted in Forbes featuring Juvenescence CEO, Dr. Greg Bailey, MD.

August 25, 2019

Read More
Juvenescence

Barclays: ‘New Advances in the Biology of Aging’

Jim Mellon, Chairman of Juvenescence, speaks with Barclays as part of the ‘Beyond 100’ program, about the science of longevity and the implications of living until 120 years.

May 9, 2019

Read More

Contact Us

We are here to help answer any questions you might have.